Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 5 Carboplatin 4 X-Rays 3 Rituximab 3 Prednisone 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Abiraterone Acetate 3 trastuzumab deruxtecan 2 talquetamab 2 pertuzumab 2 pembrolizumab 2 olaparib 2 niraparib 2 erdafitinib 2 durvalumab 2 belzutifan 2 apalutamide 2 acalabrutinib 2 Trastuzumab 2 Sunitinib 2 Phantoms, Imaging 2 Paclitaxel 2 Immunoglobulin G 2 Disulfides 2 Dexamethasone 2 Dasatinib 2 Cyclophosphamide 2 Crizotinib 2 CT-P10 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × amivantamab × 30 days × Clear all

NCT02609776 2026-06-05

CHRYSALIS

Janssen Research & Development, LLC

Phase 1 Active not recruiting

751 enrolled 1 FDA

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡